The global glucosamine market is expected to reach USD 757.3 million by 2022, according to a new report by Grand View Research, Inc. Growing application scope of the product in the manufacturing of nutritional supplements which aid in the prevention of osteoarthritis among consumers is expected to fuel demand over the next seven years. Increasing number of vegan consumers particularly in developed countries including U.S. is expected to be another driver for the industry over the forecast period. The product is primarily manufactured from crustaceans including shrimp and crab; however, Cargill and Cyanotech have pioneered vegetarian glucosamine by extracting the ingredient from ‘aspergillus niger’ fungi.
http://www.grandviewresearch.com/industry-analysis/glucosamine-market
No comments:
Post a Comment